- Home
- ORC vs IMTX Comparison
ORC vs IMTX Comparison
Compare ORC & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORC
- IMTX
- Stock Information
- Founded
- ORC 2010
- IMTX N/A
- Country
- ORC United States
- IMTX Germany
- Employees
- ORC N/A
- IMTX N/A
- Industry
- ORC Real Estate Investment Trusts
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ORC Real Estate
- IMTX Health Care
- Exchange
- ORC Nasdaq
- IMTX Nasdaq
- Market Cap
- ORC 660.1M
- IMTX 579.8M
- IPO Year
- ORC 2013
- IMTX N/A
- Fundamental
- Price
- ORC $7.17
- IMTX $4.34
- Analyst Decision
- ORC Buy
- IMTX Strong Buy
- Analyst Count
- ORC 4
- IMTX 4
- Target Price
- ORC $9.50
- IMTX $16.67
- AVG Volume (30 Days)
- ORC 4.0M
- IMTX 420.3K
- Earning Date
- ORC 04-24-2025
- IMTX 05-20-2025
- Dividend Yield
- ORC 20.08%
- IMTX N/A
- EPS Growth
- ORC N/A
- IMTX N/A
- EPS
- ORC 0.46
- IMTX 0.14
- Revenue
- ORC $52,240,000.00
- IMTX $161,336,577.00
- Revenue This Year
- ORC N/A
- IMTX N/A
- Revenue Next Year
- ORC $51.24
- IMTX $4.92
- P/E Ratio
- ORC $15.64
- IMTX $29.94
- Revenue Growth
- ORC N/A
- IMTX 188.60
- 52 Week Low
- ORC $5.69
- IMTX $3.30
- 52 Week High
- ORC $9.01
- IMTX $13.77
- Technical
- Relative Strength Index (RSI)
- ORC 52.68
- IMTX 44.99
- Support Level
- ORC $6.28
- IMTX $3.94
- Resistance Level
- ORC $7.44
- IMTX $5.41
- Average True Range (ATR)
- ORC 0.19
- IMTX 0.34
- MACD
- ORC 0.08
- IMTX -0.01
- Stochastic Oscillator
- ORC 76.29
- IMTX 27.21
About ORC Orchid Island Capital Inc.
Orchid Island Capital Inc is a specialty finance company that invests in residential mortgage-backed securities. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.